| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 75.32M | 69.49M | 62.59M | 62.34M | 69.15M | 53.39M |
| Gross Profit | 43.37M | 45.72M | 41.10M | 38.35M | 45.04M | 35.88M |
| EBITDA | 9.52M | 8.26M | 7.10M | -333.00K | 4.68M | 12.13M |
| Net Income | 1.30M | 1.00M | 610.00K | -4.94M | -86.00K | 6.42M |
Balance Sheet | ||||||
| Total Assets | 57.29M | 49.72M | 45.12M | 52.31M | 51.11M | 38.95M |
| Cash, Cash Equivalents and Short-Term Investments | 2.82M | 2.76M | 2.00M | 1.96M | 3.78M | 5.88M |
| Total Debt | 31.73M | 25.10M | 25.40M | 33.98M | 27.99M | 22.25M |
| Total Liabilities | 49.68M | 40.02M | 36.69M | 43.02M | 37.70M | 29.45M |
| Stockholders Equity | 7.60M | 9.70M | 8.43M | 9.29M | 13.41M | 9.51M |
Cash Flow | ||||||
| Free Cash Flow | 5.78M | 7.12M | 6.75M | 4.41M | 793.00K | 5.71M |
| Operating Cash Flow | 10.47M | 10.95M | 8.59M | 9.34M | 4.31M | 7.64M |
| Investing Cash Flow | -5.02M | -4.08M | -1.85M | -5.18M | -3.76M | 3.06M |
| Financing Cash Flow | -5.72M | -6.12M | -6.33M | -5.97M | -2.64M | -7.78M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £1.41B | 23.58 | 5.88% | 1.18% | 9.51% | -31.96% | |
70 Outperform | £39.88M | -3.95 | 15.03% | ― | 16.66% | 147.92% | |
65 Neutral | £1.69B | 6.72 | 121.78% | 3.99% | 3.78% | 3.29% | |
63 Neutral | £527.82M | 11.70 | 7.92% | ― | 13.21% | -54.35% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
53 Neutral | £49.85M | -28.65 | -10.09% | 2.09% | -5.97% | 14.75% | |
52 Neutral | £50.98M | -3.03 | -43.73% | ― | -38.64% | -792.57% |